Epistem Limited is a limited liability company specializing in biotechnology-driven research and development solutions. Founded in October 2017 under Reg. 11031998, Epistem operates from its headquarters at The Incubator Building, Manchester, M13 9XX. The company’s core business involves providing a range of services tailored to support pharmaceutical companies throughout the drug discovery process – from initial research and preclinical studies through early clinical trials. Epistem focuses heavily on developing novel models, platforms, and tools designed for enhanced data analysis and interpretation. Their expertise spans across various stages of development, including target identification, lead optimization, and formulation science. The company’s international presence is a key element of its strategy, reflecting the growing demand for specialized biotech services globally. Epistem currently employs a team of skilled professionals with demonstrated capabilities in biotechnology research and data analysis. As an active entity, Epistem Limited maintains a strong focus on innovation and strategic partnerships within the rapidly evolving pharmaceutical landscape. Epistem operates under SIC codes related to Research and Experimental Development on Biotechnology. The company is classified as a Worker (A rating) visa holder, representing a commitment to contributing to the biotechnology sector.

Epistem Limited is a limited liability company specializing in biotechnology-driven research and development solutions. Founded in October 2017 under Reg. 11031998, Epistem operates from its headquarters at The Incubator Building, Manchester, M13 9XX. The company’s core business involves providing a range of services tailored to support pharmaceutical companies throughout the drug discovery process – from initial research and preclinical studies through early clinical trials. Epistem focuses heavily on developing novel models, platforms, and tools designed for enhanced data analysis and interpretation. Their expertise spans across various stages of development, including target identification, lead optimization, and formulation science. The company’s international presence is a key element of its strategy, reflecting the growing demand for specialized biotech services globally. Epistem currently employs a team of skilled professionals with demonstrated capabilities in biotechnology research and data analysis. As an active entity, Epistem Limited maintains a strong focus on innovation and strategic partnerships within the rapidly evolving pharmaceutical landscape. Epistem operates under SIC codes related to Research and Experimental Development on Biotechnology. The company is classified as a Worker (A rating) visa holder, representing a commitment to contributing to the biotechnology sector.